Grifols在诊断前12年找到Parkinson的生物标志,帮助早期发现和治疗。 Grifols finds Parkinson’s biomarkers up to 12 years before diagnosis, aiding early detection and treatment.

Grifols发现,根据利用多个蛋白质组学平台对等离子体样本进行的大规模分析,帕金森病的生物症状在诊断前12年可能出现。 Grifols has found that biological signs of Parkinson’s disease may appear up to 12 years before diagnosis, based on a large-scale analysis of plasma samples using multiple proteomics platforms. 该研究是Chronos-PD方案的一部分,由Michael J资助。 The study, part of the Chronos-PD program and funded by the Michael J. Fox基金会,已确定的早期分子信号和潜在的生物标志与神经发炎和血脑屏障问题相关联。 Fox Foundation, identified early molecular signals and potential biomarkers linked to neuroinflammation and blood-brain barrier issues. 在AD/DDTM 2026年会议上介绍的结果强调了该平台对帕金森氏病的早期发现、更好的患者分组和未来精确治疗的潜力,这影响到美国近100万人。 Results, presented at the AD/PD™ 2026 conference, highlight the platform’s potential for early detection, better patient grouping, and future precision treatments for Parkinson’s, which affects nearly 1 million people in the U.S.